Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
12-week Phase II double-blind randomized COPD trial of AZD9668 with tiotropium
2009-014594-40Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing AZD9668 + Spiriva with Placebo + Spiriva (2 arms). Primary endpoint: AWT-Pi10. Started Oct 2009; status: completed.
02
Drugs
alvelestat
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2009-014594-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014594-40.